medigraphic.com
ISSN 1561-3038 (Print)

2013, Number 2

<< Back Next >>

Rev Cubana Med Gen Integr 2013; 29 (2)

Clinical significance of Chlamydias

Llorente MD, Mauriz GME, Cedeño LS

Language: Spanish
References: 40
Page:
PDF size: 73.40 Kb.


ABSTRACT

Background: Chlamydia Infections have reached high incidence in the world. They are important pathogens for both animals and man. In humans, they can cause multiple infections in different organs and organ systems.
Objective: to summarize the most novel aspects related to Chlamydias with regard to their characteristics and ways to avoid them.
Methods: a bibliographic review on the clinical importance of Chlamydias and their high incidence in humans was conducted. The MEDLINE database available in INFOMED was consulted; from which bibliographic references were taken between the years 1995 and 2011 about some etiologic, clinical, diagnostic and therapeutic aspects in relation to the latest relevant notes appearing in the medical literature about Chlamydias and their relation with the man.
Results: Chlamydia Trachomatis, in particular, the responsible for trachoma and the first cause of preventable blindness, causes a deleterious impact on reproductive health, leading to entities such as spontaneous abortions, premature rupture of membranes, intrauterine growth restriction, endometritis, conjunctivitis, and pneumonia in the newborn. It is also responsible for Lymphogranuloma Venereum (LGV), Nongonococcal Urethritis (NGU), Reiter's syndrome, Pelvic Inflammatory Disease, Fitz-Hugh-Curtis Syndrome, Chronic Ectopic Pregnancy, Chronic Pelvic Pain, and most recently, Cervical Carcinoma, among others.
Conclusions: on the basis of social and economic impact that the infections by Chlamydias have in the world and in our country, we could summarize the most recent aspects in relation to types, infections that they cause and their characteristics, diagnosis, therapy and general measures to avoid them or reduce their negative impact on society.


REFERENCES

  1. Reynerio Facundo F. Chlamydia. Actualización en entidades patológicas y pruebas diagnósticas.Rev Mex Patol Clin. 2000; 47(4): 242-4.

  2. Ausina Ruiz V, Sabrià Leal M: Infecciones causadas por clamidias, en Farreras Valentí P, Rozman C: Medicina Interna, (2)303:2694-2699, 14ª Harcourt, Madrid, 2000.

  3. Martínez T. M. Angélica, Diomedi P. ALEXIS, KOGAN A. RICARDO, BORIE P. CONSUELO. Taxonomía e importancia clínica de las nuevas familias del orden Chlamydiales. Rev. chil. infectol. [revista en la Internet]. 2001 [citado 2012 Ene 22]; 18(3): 203-211. Disponible en: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716- 10182001000300007&lng=es. doi: 10.4067/S0716-10182001000300007.

  4. Friedman M G, Galil A, Greenberg S, Kahane S. Seroprevalence of IgG antibodies to the chlamydia-like microorganism "Simkania Z" by ELISA. Epidemiol Infect 1999; 122: 117-23.

  5. Kahane S, Greenberg D, Friedman M G, Haikin H, Dagan R. High prevalence of "Simkania Z", a novel Chlamydia-like bacterium, in infants with acute bronchiolitis. J Infect Dis 1998; 177: 1425-9.

  6. Andersen AA, Vanrompay D. Avian chlamydiosis. Rev Sci Tech 2000; 19: 396-404.

  7. Hadley K M, Carrington D, Frew C E, Gibson A A M, Hislop W S. Ovine chlamydiosis in an abattoir worker J Infect 1992; 25 Suppl 1: 105-9.

  8. Dal Molin G, Longo B, Not T, Poli A, Campello C. A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren. J Clin Pathol 2005; 58: 617-20.

  9. Bardají A, Alonso J, García-Moll X, Bueno H. Actualización en cardiopatía isquémica 2005. Rev Esp Cardiol [en línea] 2006 [fecha de acceso 7 de marzo de 2006]; 59: 3 - 19. Disponible en: http://www.revespcardiol.org/cgi-bin/wdbcgi.exe/cardio /mrevista_cardio.fulltext?pident=13084444

  10. Gurfinkel E P. Infección y aterosclerosis. Rev Esp Cardiol [en línea] 2001[fecha de acceso 10 de febrero de 2006]; 54: 383-92. Disponible en: http://www.revespcardiol.org/cgibin/wdbcgi.exe/cardio/mrevista_cardio.fulltext?pi dent=10021525

  11. García-Elorriaga GA, Calderón-Abbo M, González-Bonilla CR. Asociación entre Enfermedad cardiovascular y anticuerpos contra Chlamydia pneumoniae. Salud Pública Mex 2002; 44:243-246.

  12. Clarke J. Predicting bacterial cause in infectious conjunctivitis: Chlamydia needs to be taken into account. BMJ 2004; 329: 625.

  13. Ruvalcaba E, Muñoz D, Perez E. Embarazo ectópico crónico como masa anexial. Rev Chil Obstet Ginecol 2005; 70(2): 95-98.

  14. Levy NB, Goldberger SB, Batchelder CS. Chronic ectopic pregnancy. A survey of 54 cases. S Afr Med J 1996; 65:727-29.

  15. Giuliano Anna R, Denman C., Guernsey de Z., Navarro H., Ortega L., Djambazov B., Brown de Galaz E., Hatch K. Design and results of the USA - Mexico Border Human Papilomavirus (HPV), Cervical Dysplasia, and Chlamydia trachomatis Study .Revista Panamericana de Salud Pública. OPS. 2001;9 (3) Marzo 172-80.

  16. Bañó Aracil M, González Morán F, Berto Blanch F, Bellido Blasco J, Sánchez Linares E, Arnedo Pena A, et al.Brote familiar de neumonía por psitacosis. Med Clin(Barc) 1995; 99: 262-264.

  17. Verweij P, Meis J, Eijk R, Melchers W, Galama J,Severe human psitacosis requiring artificial ventilation. Case report and review. Clin Infect Dis 1995; 20: 440-442.

  18. McCracken JR. Etiology and treatment of pneumonia. Pediatr Infect Dis 2000; 19:373-7.

  19. Gencay M, Roth M"Infecciones por Chlamydia pneumoniae en el Asma. Impacto Clínico." American Journal of Respiratory Medicine 2003; 2(1):31-38.

  20. Parada C María Teresa, Kauffmann Q Ronald. Síndrome coronario agudo asociado a neumonía por Chlamydia pneumoniae, en dos casos: Report of two cases. Rev. méd. Chile . 2000; 128(2): 201-205.

  21. Blasi C.: The role of the infectious agents in the pathogenesis and evolution of atherosclerosis. Ann Ital Med Int. 2004;19(4): Oct-Dec 249-61

  22. Mariotti SP. New steps toward eliminating blinding trachoma (editorial). N Engl J Med 2004; 351: 2004-7.

  23. Young F. Sexually transmitted infections. Genital chlamydia: practical management in primary care. J Fam Health Care 2005; 15: 19-21.

  24. Van der Bij Ak, Spaargaren J, Morré SA. Factores de riesgo y predictores clinicos del Linfogranuloma Venéreo Anorrectal. Clinical Infectious Diseases. 2006; 42(2):186- 194.

  25. Guerra_Infante F, Flores_Medina S, Arteaga_Troncoso G, Zamora_Ruiz A, López_Hurtado M, Ortiz_Ibarra FJ. Factores de riesgo y secuelas reproductivas asociados a la infección por Chlamydia trachomatis en mujeres infértiles. Salud Pública Mex 2003; 45(Suple 5): S672-S680.

  26. Weir E. Lymphogranuloma venereum in the differential diagnosis of proctitis. CMAJ 2005; 172: 185.

  27. Simpson T, Oh MK. Urethritis and cervicitis in adolescents. Adolesc Med Clin 2004; 15: 253-71.

  28. Falk, Lars, Hans Fredlund, and J. S. Jensen. Signs and symptoms of urethritis and cervicitis among women with or without Mycoplasma genitalium or Chlamydia trachomatis infection. Sexually Transmitted Infections. 2005; 81 (1): 73-78.

  29. Wiesenfeld HC, Sweet RL, Ness RB, Krohn MA, Amortegui AJ, Hillier SL. Comparison of acute and subclinical pelvic inflammatory disease. Sex Transm Dis 2005; 32: 400-5.

  30. Sharma JB, Malhotra M, Arora R. Fitz-Hugh-Curtis syndrome as a result of genital tuberculosis: a report of three cases. Acta Obstet Gynecol Scand 2003; 82(3):295-7.

  31. Takeshita T, Shima H, Oishi S, Machida N, Kashima R, Ohno S, Uchiyama Fitz- Hugh-Curtis syndrome: Hepatic capsular enhancement and diffuse gallbladder wall thickening on contrast-enhanced CT. Intern Med 2004; 43: 632-3.

  32. Burton E, McKeating J, Stahlfeld K. Laparoscopic management of a small bowe obstruction of unknown cause obstruction of unknown cause. .N Engl Journal of Med 2008; 12(3):299-302.

  33. Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infect Dis Clin North Am. 2006; 20 (5): 827-47.

  34. Butler C. Are all genital Chlamydia trachomatis infections pathogenic? Sex Transm Infect 2005; 81: 187.

  35. Zar HJ. Neonatal chlamydial infections: Prevention and treatment. Paediatr Drugs 2005; 7: 103-10.

  36. Black CM. "Current methods of laboratory diagnosis of Chlamydia trachomatis infections". Clin Microbiol Rev 2003; 7: 160-164.

  37. Tan HH, Chan R. Use of polymerase chain reaction on pooled cervical swabs to detect Chlamydia trachomatis infections in female sex workers in Singapore. Singapore Med J 2005; 46: 215.

  38. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004; 351: 1962-71.

  39. Fernández F, Gutiérrez J, Mendoza J, Linares J, Soto MJ. A new microimmunofluorescence test for the detection of Chlamydia pneumoniae specific antibodies. J Basic Microbiol 2004; 44: 275-9.

  40. Erbelding EJ, Zenilman JM. Better control of sexually transmitted diseases.N Engl J Med 2005; 352: 720-1.




2020     |     www.medigraphic.com